Boston Scientific (BSX)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:373
% of all portfolios:0.006%
Hold Price * :$57.81
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q1  2008
≡ Robert Olstein - Olstein Capital Management Reduce 13.55% 311,083 0.36
Q4  2007
≡ Dodge & Cox Add 0.01% 4,000 0.00
≡ Robert Olstein - Olstein Capital Management Reduce 0.19% 4,300 0.00
≡ Harry Burn - Sound Shore Reduce 27.73% 2,225,000 0.97
Q3  2007
≡ Dodge & Cox Add 94.88% 22,013,600 0.45
≡ Robert Olstein - Olstein Capital Management Add 56.74% 832,900 0.74
≡ Harry Burn - Sound Shore Add 52.09% 2,748,100 1.33
≡ David Katz - Matrix Asset Advisors Sell 100.00% 422,000 2.90
Q2  2007
≡ Harry Burn - Sound Shore Add 27.34% 1,132,700 0.59
≡ David Katz - Matrix Asset Advisors Add 7.93% 31,000 0.21
≡ Robert Olstein - Olstein Capital Management Buy 1,467,900 1.31
≡ Dodge & Cox Buy 23,201,500 0.51
Q1  2007
≡ David Katz - Matrix Asset Advisors Add 16.72% 56,000 0.44
≡ Harry Burn - Sound Shore Add 16.38% 583,300 0.30

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.